<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Distribution of serum CK in different population groups</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Distribution of serum CK in different population groups</h1>
<div class="graphic"><div class="figure"><div class="ttl">Distribution of serum CK in different population groups</div><div class="cntnt"><table cellspacing="0"><colgroup width="25%"></colgroup><colgroup span="7" width="10%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Sex and ancestry</td> <td class="subtitle1" rowspan="2">N</td> <td class="subtitle1" rowspan="2">Age</td> <td class="subtitle1" rowspan="2">BMI</td> <td class="subtitle1" colspan="3">Serum CK distribution</td> <td class="subtitle1" rowspan="2">&gt;ULN (N %)*</td> </tr> <tr> <td class="subtitle2">2.5<sup>th </sup>percentile</td> <td class="subtitle2">Median</td> <td class="subtitle2">97.5<sup>th</sup> percentile</td> </tr> <tr> <td class="sublist1_start">All subjects<sup>¶</sup></td> <td>1411</td> <td>45 (7)</td> <td>27 (5)</td> <td>40</td> <td>111</td> <td>460</td> <td>508 (36)</td> </tr> <tr> <td class="sublist1">Women</td> <td class="sublist_other">831</td> <td class="sublist_other">45 (7)</td> <td class="sublist_other">28 (6)</td> <td class="sublist_other">36</td> <td class="sublist_other">95</td> <td class="sublist_other">349</td> <td class="sublist_other">304 (37)</td> </tr> <tr> <td class="sublist1">Men</td> <td class="sublist_other">580</td> <td class="sublist_other">46 (7)</td> <td class="sublist_other">26 (4)</td> <td class="sublist_other">51</td> <td class="sublist_other">143</td> <td class="sublist_other">616</td> <td class="sublist_other">204 (35)</td> </tr> <tr> <td class="sublist1_start">White subjects</td> <td>503</td> <td>48 (7)</td> <td>26 (5)</td> <td>35</td> <td>88</td> <td>286</td> <td>64 (13)</td> </tr> <tr> <td class="sublist1">Women</td> <td class="sublist_other">252</td> <td class="sublist_other">47 (7)</td> <td class="sublist_other">26 (5)</td> <td class="sublist_other">29</td> <td class="sublist_other">72</td> <td class="sublist_other">201</td> <td class="sublist_other">21 (8)</td> </tr> <tr> <td class="sublist1">Men</td> <td class="sublist_other">251</td> <td class="sublist_other">48 (7)</td> <td class="sublist_other">26 (4)</td> <td class="sublist_other">47</td> <td class="sublist_other">110</td> <td class="sublist_other">322</td> <td class="sublist_other">43 (17)</td> </tr> <tr> <td class="sublist1_start">South Asian subjects</td> <td>270</td> <td>44 (6)</td> <td>27 (5)</td> <td>40</td> <td>104</td> <td>382</td> <td>62 (23)</td> </tr> <tr> <td class="sublist1">Women</td> <td class="sublist_other">147</td> <td class="sublist_other">45 (6)</td> <td class="sublist_other">27 (5)</td> <td class="sublist_other">37</td> <td class="sublist_other">87</td> <td class="sublist_other">313</td> <td class="sublist_other">23 (16)</td> </tr> <tr> <td class="sublist1">Men</td> <td class="sublist_other">123</td> <td class="sublist_other">44 (6)</td> <td class="sublist_other">26 (5)</td> <td class="sublist_other">47</td> <td class="sublist_other">143</td> <td class="sublist_other">641</td> <td class="sublist_other">39 (32)</td> </tr> <tr> <td class="sublist1_start">Black subjects</td> <td>570</td> <td>44 (6)</td> <td>28 (5)</td> <td>51</td> <td>149</td> <td>627</td> <td>278 (49)</td> </tr> <tr> <td class="sublist1">Women</td> <td class="sublist_other">387</td> <td class="sublist_other">43 (6)</td> <td class="sublist_other">29 (6)</td> <td class="sublist_other">48</td> <td class="sublist_other">124</td> <td class="sublist_other">414</td> <td class="sublist_other">164 (42)</td> </tr> <tr> <td class="sublist1">Men</td> <td class="sublist_other">183</td> <td class="sublist_other">44 (6)</td> <td class="sublist_other">26 (4)</td> <td class="sublist_other">71</td> <td class="sublist_other">213</td> <td class="sublist_other">801</td> <td class="sublist_other">114 (62)</td> </tr> </tbody></table></div><div class="graphic_lgnd">Data for age and body mass index (BMI) are means (SD). Data are rounded to the nearest integer. CK is expressed as international units per liter.</div><div class="graphic_footnotes">CK: creatine kinase; BMI: body mass index; ULN: upper limit of normal.<br/>* Number (percentage) of participants with a CK above the ULN, as recommended by the manufacturer (140 international units/L for women, 174 international units/L for men; with appropriately established reference intervals, 2.5% of the subjects are expected to have values above the ULN).<br/>¶ Including participants of "other" ancestry (n = 68), with the exclusion of outliers (n = 3, 1 South Asian participants and 2 Black participants) and those using statins (n = 30, 21 South Asian participants, 8 Black participants, and 1 of other ancestry).</div><div class="graphic_reference">Reproduced with permission from: Brewster, LM, Mairuhu, G, Sturk, A, van Montfrans, GA. Distribution of creatine kinase in the general population: Implications for statin therapy. Am Heart J 2007; 154:655. Copyright ©2007 Elsevier.</div><div id="graphicVersion">Graphic 70806 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
